Laura Hamill's most recent trade in Y-Mabs Therapeutics Inc was a trade of 33,450 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Y-Mabs Therapeutics Inc | Laura J. Hamill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 33,450 | 33,450 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Laura J. Hamill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 25,080 | 30,905 (0%) | 0% | 0 | Common Stock | |
| Jazz Pharmaceuticals plc | Laura J. Hamill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2024 | 3,731 | 5,231 (0%) | 0% | 0 | Ordinary Shares | |
| Y-Mabs Therapeutics Inc | Laura J. Hamill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 14,545 | 14,545 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Laura J. Hamill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 3,495 | 5,825 (0%) | 0% | 0 | Common Stock | |
| Scilex Holding Company | Laura J. Hamill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 250,000 | 250,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| AnaptysBio Inc | Laura J. Hamill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 10,600 | 10,600 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Laura J. Hamill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 3,900 | 3,900 | - | - | Restricted Stock Unit | |
| Y-Mabs Therapeutics Inc | Laura J. Hamill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 16,000 | 16,000 | - | - | Non-Employee Stock Option (right to buy) | |
| AnaptysBio Inc | Laura J. Hamill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 9,200 | 9,200 | - | - | Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | Laura Hamill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 16,000 | 16,000 | - | - | Non-Employee Stock Option (right to buy) | |
| AnaptysBio Inc | Laura Hamill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2021 | 11,000 | 11,000 | - | - | Stock Option (right to buy) |